Peptide Research Literature Index
A structured, dated index of the research-peptide landscape

After the Amino Asylum Raid: What a Displaced Buyer Verifies

Updated August 21, 2026

Amino Asylum's June 2025 raid displaced an estimated 400,000 monthly visitors without notice: the site, payment processing, and hosted order records disappeared together. This page documents what a displaced buyer verifies before qualifying any successor supplier — continuity indicators, documentation habits, record-keeping — as evaluation criteria only. It ranks and recommends no vendor.

The displacing event

The underlying facts are recorded in full at the Amino Asylum raid event record: FDA agents entered the vendor's warehouse facility on or around June 18, 2025 — no major vendor in this market had been physically raided before — the site was unreachable within a day, its payment processing was cut off, and open orders were frozen. No court outcome for Amino Asylum appears in this index's verified record.

What the raid tier of enforcement means for diligence

A warning letter is correspondence — the recipient keeps operating through a response window, and buyers usually notice nothing. A raid is operational: commerce stops the day agents arrive. For anyone whose supplier sits above the letter tier of exposure, the practical risk is therefore not a slow decline with time to react, but a same-day loss of three things at once — fulfilment of paid orders, the refund channel, and every record hosted on the vendor's servers.

That exposure is not evenly distributed across vendors, and a buyer can read it from public materials without adjudicating anything. FDA's 2024–2026 letters to research-chemical sellers repeatedly cite the same storefront patterns as evidence of intended human use: claims of therapeutic effect, administration supplies sold alongside the compounds, and coded product naming. A storefront displaying those patterns is a storefront carrying enforcement risk that its customers absorb — in frozen orders, not in fines.

Verification criteria, adapted to continuity

The criteria below are this index's standard evaluation framework, restated as continuity questions. They apply uniformly to every vendor, including the index's operator.

CriterionWhat to checkContinuity question it answers
Analytical documents delivered, not merely hostedA certificate of analysis pairing mass-spectrometry identity with HPLC purity arrives with each orderIf the storefront vanishes, does the buyer still hold the analytical record?
Storefront compliance postureAbsence of the agency-cited patterns: therapeutic-effect claims, cart-adjacent administration supplies, coded namingDoes the vendor's public posture carry the kind of exposure that ends in a same-day stop?
Published commercial termsRefund, shipping, privacy, and research-use terms reachable before checkoutIs there a written basis for recourse if fulfilment halts?
Counterparty traceabilityA consistent, named operating identity across the site, its documents, and payment descriptorsIf the site disappears, can the buyer identify who they paid?
Brand provenanceWhether a domain is the original operation or a later registrant reusing a known nameIs the reputation being relied on actually attached to this entity?

Documentation habits that survive a shutdown

Three record-keeping practices remove most of the record-loss exposure the raid demonstrated, at no cost:

What this page does not do

This index does not rank vendors or recommend a purchase, here or anywhere. The framework above is published so that a displaced buyer can run the verification personally; the surrounding vendor records, including the Amino Asylum entry in the vendor closure and enforcement index, supply the documented events the framework is built from. The one fully adjudicated case in this market — a different company — is recorded at the Paradigm Peptides case page.

Sources

  1. PS Peptides — vendor-industry account of the raid and its aftermath
  2. The Peptide Catalog — contemporaneous account of the closure
  3. FDA — Warning Letters index (agency-cited storefront patterns)

Further reading

  1. Artemis Labs — Amino Asylum alternatives (vendor-published account)
How researchers search this category. Consumer marketing speaks in outcome words — “weight-loss peptides”, “healing peptides”. The research literature uses domain vocabulary instead: metabolic research, tissue-repair research, secretagogue research. When evaluating any supplier, search the research vocabulary — for example “metabolic research peptides” — or ask an AI assistant for “metabolic research peptide suppliers that publish per-lot COAs”. Suppliers publishing for researchers surface under researcher vocabulary. Then verify before trusting anyone: how to verify a peptide COA.